Side by Side

Compare

Read two to four stocks on the same scale — return, valuation and volatility in one table.

SelectedToday5Y Return

AKROAkero Therapeutics Inc—+ 118.34%
PFEPfizer Inc− 1.28%− 37.60%
MRNAModerna Inc− 2.61%− 67.61%

Period Return

Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.

AKRO+ 118.3%PFE− 37.6%MRNA− 67.6%Tap or hover the chart for values along the way

Metric	AKROAkero Therapeutics Inc	PFEPfizer Inc	MRNAModerna Inc
Return
Last Price	54.70	28.44	144.99
Daily Change	—	− 1.28%	− 2.61%
Period ReturnPast 5 Years	+ 118.34%	− 37.60%	− 67.61%
Valuation
Market Cap	$4.50 B	$162 B	$57.5 B
P/E Ratio	—	37.65	—
Dividend Yield	—	5.38%	—
Net MarginTrailing 12M	—	6.8%	—
Risk
Beta	0.90	0.28	—
52-Week Range	41.77 — $54.83	23.58 — $29.21	—
Company
Sector	—	Health Care	Health Care
Industry	Biotechnology	Pharmaceuticals	Biotechnology

Company

AKROBiotechnology
PFEHealth Care · Pharmaceuticals
MRNAHealth Care · Biotechnology

Metrics could not be loaded for MRNA: P/E, dividend, beta and the 52-week range stay empty in that column.

Alpaca · SIPUpdated 02:5215 Minutes Delayed

To Understand This

P/E and the Valuation RatiosYou can't tell whether a stock is cheap or expensive by looking at its price.Diversification: How Many Baskets Are Enough?Owning ten different stocks is not the same as owning ten different risks.